Iodine-131 anti-B1 antibody for B-cell lymphoma: An update on the Michigan phase I experience

Journal of Nuclear Medicine

Volumn 39, Issue 8, 1998, Pages

  Wahl, R L ^a   Zasadny, K R ^a   Macfarlane, D ^a   Francis, I R ^a   Ross, C W ^a   Estes, J ^a   Fisher, S ^a   Regan, D ^a   Kroll, S ^a   Kaminski, M S ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

B cell lymphoma; Iodine 131 anti B1 antibody; Non Hodgkin's lymphoma; Radioimmunotherapy

Indexed keywords

IODINE 131; MONOCLONAL ANTIBODY;

ADULT; ANTINEOPLASTIC ACTIVITY; ARTICLE; B CELL LYMPHOMA; BONE MARROW TRANSPLANTATION; CANCER SURVIVAL; CLINICAL ARTICLE; DOSE CALCULATION; FEMALE; GENE TARGETING; HUMAN; MALE; PRIORITY JOURNAL; RADIATION DOSE; RADIOIMMUNOTHERAPY; TARGET CELL; THROMBOCYTOPENIA;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD20; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IODINE RADIOISOTOPES; LYMPHOMA, B-CELL; MALE; RADIOIMMUNOTHERAPY; RADIOTHERAPY DOSAGE; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 0031828752     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)